[go: up one dir, main page]

MX2018009748A - Composiciones que contienen cromo para mejorar la salud y el estado físico. - Google Patents

Composiciones que contienen cromo para mejorar la salud y el estado físico.

Info

Publication number
MX2018009748A
MX2018009748A MX2018009748A MX2018009748A MX2018009748A MX 2018009748 A MX2018009748 A MX 2018009748A MX 2018009748 A MX2018009748 A MX 2018009748A MX 2018009748 A MX2018009748 A MX 2018009748A MX 2018009748 A MX2018009748 A MX 2018009748A
Authority
MX
Mexico
Prior art keywords
muscle
fitness
containing compositions
chromium containing
improving health
Prior art date
Application number
MX2018009748A
Other languages
English (en)
Inventor
R Komorowski James
Original Assignee
Nutrition 21 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 Llc filed Critical Nutrition 21 Llc
Publication of MX2018009748A publication Critical patent/MX2018009748A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La administracion de ciertos complejos de cromo en combinacion con un almidon proporciona beneficios inesperados con respecto a la absorcion creciente de aminoacidos, sintesis de proteina, tolerancia al ejercicio, masa muscular, hipertrofia del musculo esqueletico, potencia muscular, resistencia muscular, fuerza muscular, FSR y disminucion del dolor muscular de aparición tardia, ruptura de proteinas musculares y masa de grasa.
MX2018009748A 2016-02-11 2017-02-08 Composiciones que contienen cromo para mejorar la salud y el estado físico. MX2018009748A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662285014P 2016-02-11 2016-02-11
PCT/US2017/016946 WO2017139337A1 (en) 2016-02-11 2017-02-08 Chromium containing compositions for improving health and fitness

Publications (1)

Publication Number Publication Date
MX2018009748A true MX2018009748A (es) 2019-02-07

Family

ID=58108736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009748A MX2018009748A (es) 2016-02-11 2017-02-08 Composiciones que contienen cromo para mejorar la salud y el estado físico.

Country Status (8)

Country Link
US (3) US11865121B2 (es)
EP (1) EP3413900A1 (es)
CN (1) CN109069532A (es)
AU (3) AU2017217466A1 (es)
CA (1) CA3014308A1 (es)
GB (1) GB2564295A (es)
MX (1) MX2018009748A (es)
WO (1) WO2017139337A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身
US10820617B1 (en) * 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement
AR114010A1 (es) * 2018-10-17 2020-07-08 Team Foods Colombia Sa Composición lipídica con micronutrientes para la prevención y/o el tratamiento de enfermedades metabólicas
CN114540214B (zh) * 2020-11-27 2023-07-04 北京岳泰华生物科技有限公司 一种高产有机铬的微生物及其应用

Family Cites Families (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DK135268A (es) 1973-02-09
US3939259A (en) 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4164573A (en) 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
EP0016496B1 (en) 1979-03-19 1983-10-19 THE PROCTER & GAMBLE COMPANY Chromium acetylacetonate as a dietary supplement and pharmaceutical agent
US4421685A (en) 1980-03-27 1983-12-20 Eli Lilly And Company Process for producing an insulin
USRE33988E (en) 1980-08-08 1992-07-07 The United States of America as repesented by the Secretary of Agriculture Dietary supplementation with essential metal picolinates
US4315927A (en) 1980-08-08 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Dietary supplementation with essential metal picolinates
FI78616C (fi) 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
US4424057A (en) 1982-04-01 1984-01-03 House Hugh A Wet-dry syringe
JPS5927833A (ja) 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
US5194615A (en) 1983-07-08 1993-03-16 The William Seroy Group Synthetic GTF chromium nicotinate material and its preparation
US4923855A (en) 1983-07-08 1990-05-08 The William Seroy Group Synthetic GTF chromium material and process therefor
US4954492A (en) 1983-07-08 1990-09-04 The William Seroy Group Synthetic GTF chromium material for decreasing blood lipid levels and process therefor
JPS62103012A (ja) 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DK179286D0 (da) 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
US5028599A (en) 1986-05-15 1991-07-02 Emory University Method of treating mycardial damage
US5032608A (en) 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5175156A (en) 1987-11-30 1992-12-29 Nutrition 21 Chromic picolinate treatment
US5087623A (en) 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US5085996A (en) 1988-07-29 1992-02-04 Evans Gary W Microorganism growth acceleration medium containing an effective amount of picolinic acid or metal picolinate to promote growth of the microorganism
US5057320A (en) 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5087624A (en) 1989-03-21 1992-02-11 Nutrition 21 Chromic picolinate treatment
WO1991011117A2 (en) 1990-02-05 1991-08-08 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
US5614553A (en) 1990-07-06 1997-03-25 Albion Laboratories, Inc. Composition and method for alleviating stress in warm-blooded animals
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
IL99699A (en) 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5106836A (en) 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
US5114963A (en) 1991-03-13 1992-05-19 Medicis Corporation Method of reducing serum levels of lipoprotein(A)
DK0585355T3 (da) 1991-05-20 1995-06-06 Tanabe Seiyaku Co Flerlagspræparat med reguleret frigivelse
US5164384A (en) 1991-06-19 1992-11-17 Metagenics, Inc. Anabolic mineral formula
US5336672A (en) 1992-07-21 1994-08-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Increasing egg production in poultry
IT1258491B (it) 1992-09-24 1996-02-26 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
IT1256393B (it) 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
SE9203753D0 (sv) 1992-12-11 1992-12-11 Kabi Pharmacia Ab Expression system for producing apolipoprotein ai-m
US5340834A (en) 1993-01-05 1994-08-23 Stitt Paul A Method of increasing muscle mass in chickens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ATE204467T1 (de) 1993-04-22 2001-09-15 Emisphere Tech Inc Orale darreichungsform
US5534488A (en) 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5496827A (en) 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
US5744161A (en) 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5582839A (en) 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
US5776498A (en) 1995-11-06 1998-07-07 Nutrition 21 Magnesium taurate as an adjuvant to rapid thrombolytic therapy
US6099869A (en) 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
US6329361B1 (en) 1995-05-12 2001-12-11 Nutrition 21 High-dose chromic picolinate treatment of type II diabetes
US5597585A (en) 1995-12-26 1997-01-28 Williams; Andrew H. Vitamin/mineral composition
US5635535A (en) 1996-04-05 1997-06-03 Wagstaff; Robert K. Method for increasing blood glucose levels
US5937597A (en) 1996-07-18 1999-08-17 Ykk Architectural Products Inc. Multi-window sash and batten attachment structure
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5776888A (en) 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051561A (en) 1997-02-07 2000-04-18 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5707970A (en) 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US6291495B1 (en) 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
CA2323889A1 (en) 1997-03-12 1998-09-17 Robert W. Esmond A method for treating or preventing alzheimer's disease
US5888553A (en) 1997-04-08 1999-03-30 Infinity, Inc. Non-steroidal anabolic composition
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DE19722618A1 (de) 1997-05-30 1998-12-03 Philips Patentverwaltung Hochtemperaturkondensator
US5914326A (en) 1997-08-08 1999-06-22 Ambi Inc. Method for promoting weight and fat loss
WO1999007387A1 (en) 1997-08-08 1999-02-18 Nutrition 21 Chromium/biotin treatment of type ii diabetes
US5789401A (en) 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6048846A (en) 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US20040058873A1 (en) 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
US6245027B1 (en) 1998-04-10 2001-06-12 Noam Alperin Method of measuring intracranial pressure
US5948772A (en) 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof
JP4675481B2 (ja) 1998-07-27 2011-04-20 エミスフェアー・テクノロジーズ・インク 活性剤の肺性デリバリー
TR200100366T2 (tr) 1998-08-07 2001-11-21 Emisphere Technologies, Inc. Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
US5980905A (en) 1998-08-28 1999-11-09 Ambi Inc. Chromium polynicotinate compositions and uses thereof
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
EP1113804A2 (en) 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
EP1156787B1 (en) 1999-02-11 2005-11-30 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
AU3378100A (en) 1999-02-26 2000-09-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2369591C (en) 1999-04-05 2011-06-14 Emisphere Technologies, Inc. Disodium salts, monohydrate, and ethanol solvates
US6524616B1 (en) 1999-06-25 2003-02-25 Wake Forest University Health Services Compositions and methods for treating or preventing neurodegeneration and cognitive decline and dysfunction associated with alzheimer's disease, aging, other dementia related disorders and estrogen deficiency related conditions
US6955873B1 (en) 2000-08-04 2005-10-18 Kenneth Blum Diagnosis and treatment system for reward deficiency syndrome (RDS) and related behaviors
US6261606B1 (en) 1999-09-14 2001-07-17 Natural Compounds, Ltd. Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions
JP2001104702A (ja) 1999-10-01 2001-04-17 Air Liquide Japan Ltd ガスの集合回収装置および集合回収方法
DE19948361A1 (de) 1999-10-07 2001-04-12 Bsh Bosch Siemens Hausgeraete Kältegerät
US6689383B1 (en) 1999-10-08 2004-02-10 The United States Of America As Represented By The Secretary Of Agriculture Chromium-histidine complexes as nutrient supplements
EP1226104B1 (en) 1999-11-05 2009-04-08 Emisphere Technologies, Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
WO2001034114A1 (en) 1999-11-12 2001-05-17 Emisphere Technologies, Inc. Liquid heparin formulation
DE19959351A1 (de) 1999-12-09 2001-06-13 Bilstein Spezialfab Wilhelm Schneidvorrichtung mit Eigenantrieb für eine Einrichtung zum Längsteilen von durchlaufenden Materialbahnen
JP4850379B2 (ja) 1999-12-16 2012-01-11 エミスフェアー・テクノロジーズ・インク 活性剤を輸送するための化合物及び組成物
AU2001236457A1 (en) 2000-01-13 2001-07-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU2001229672A1 (en) * 2000-01-20 2001-07-31 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fatin humans
US6521591B1 (en) 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US20070179197A1 (en) 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
IT1318524B1 (it) 2000-05-17 2003-08-27 Ambros Pharma S R L Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
DK1299348T3 (da) 2000-06-29 2008-07-28 Emisphere Tech Inc Forbindelser og sammensætninger til levering af aktive midler
JP2002043557A (ja) 2000-07-21 2002-02-08 Mitsubishi Electric Corp 固体撮像素子を有する半導体装置およびその製造方法
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
ATE396967T1 (de) 2000-09-06 2008-06-15 Emisphere Tech Inc (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
EP1317419B1 (en) 2000-09-06 2009-04-22 Emisphere Technologies, Inc. Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
US6809115B2 (en) * 2000-09-21 2004-10-26 Nutrition 21, Inc. Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
UA77660C2 (en) 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
AU2002232471A1 (en) 2000-10-31 2002-05-15 Nutrition 21, Inc. Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes
US20020098247A1 (en) 2000-11-02 2002-07-25 Komorowski James R. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
US6579866B2 (en) 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
PT1397148E (pt) 2001-02-27 2006-11-30 Nutrition 21 Inc Tratamento da dislipidemia com crómio/biotina
MXPA03007857A (es) 2001-03-01 2004-05-24 Emisphere Tech Inc Compuestos y composiciones para entregar agentes activos.
RU2309945C2 (ru) 2001-03-01 2007-11-10 Эмисфере Текнолоджиз, Инк. Композиции для доставки бисфосфонатов
AU2002336759A1 (en) 2001-09-21 2003-04-14 Accera, Inc. Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
WO2003043569A2 (en) 2001-11-16 2003-05-30 Nutrition 21, Inc. Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
US20030198666A1 (en) 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
JP2005525401A (ja) 2002-04-23 2005-08-25 ニュートリション ２１、インコーポレイテッド 薬剤誘発インスリン抵抗性を阻害するためのクロム組成物およびその使用方法
US7063865B2 (en) 2002-05-10 2006-06-20 Jeremy Park Jones Composition and method for substantially reducing the deleterious effects of alcohol on the body
US7247328B2 (en) 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US20040005368A1 (en) 2002-07-01 2004-01-08 Morris Mann Novel approach to weight loss comprising a modified protein composition that regulates blood sugar in conjunction with compositions that increase oxygen uptake and suppress appetite
JP4419077B2 (ja) 2002-10-11 2010-02-24 アステラス製薬株式会社 Ｃａｐ結合蛋白質
US20040115265A1 (en) 2002-12-11 2004-06-17 Loutfy Benkerrour Multilayered tablet containing pravastatin and aspirin and method
US20040185119A1 (en) 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
US7291591B2 (en) 2003-04-11 2007-11-06 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition
BRPI0410962A (pt) 2003-06-04 2006-07-04 Willem Jacob Serfontein composição de suplementação de nutrientes ou combinação de composições, e, uso de uma composição ou combinação de composições e de uma composição de nutrientes ou combinação de composições
PL1667665T3 (pl) 2003-09-03 2009-06-30 Pharmaton Sa Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalniania
US20050069593A1 (en) 2003-09-29 2005-03-31 Life Time Fitness, Inc. Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US20060024383A1 (en) 2004-07-27 2006-02-02 Roger Berlin Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses
US20060062859A1 (en) 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
US20080206415A1 (en) * 2004-10-07 2008-08-28 Next Proteins, Inc. Protein beverage and method of making the same
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
WO2006060753A2 (en) 2004-12-03 2006-06-08 Rhode Island Hospital Diagnosis and treatment of alzheimer's disease
US20060280795A1 (en) 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
JP2009502950A (ja) 2005-07-28 2009-01-29 レリアント ファーマスーティカルズ インコーポレイテッド ジヒドロピリジンカルシウムチャネルブロッカー及びω３脂肪酸を用いた治療法、並びにそれらの混合生成物
WO2007041268A2 (en) 2005-09-30 2007-04-12 Xenoport, Inc. Transporter-targeted methods of diagnosis and treatment
CN100446676C (zh) 2006-03-29 2008-12-31 浙江大学 控缓释型铬的补铬饲料添加剂及其制备与使用方法
WO2008094939A1 (en) 2007-01-31 2008-08-07 Nutrition 21, Inc. Use of chromium histidinate for treatment of cardiometabolic disorders
PL3050568T3 (pl) 2007-03-13 2021-06-14 Jds Therapeutics, Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
WO2009009393A2 (en) 2007-07-06 2009-01-15 Nutrition 21, Inc. Chromium complexes for improvement of memory and cognitive function
US20090099215A1 (en) * 2007-10-11 2009-04-16 Cornelius Derek W Metabolic enhancing properties of norphenephrine and its salts
WO2009075925A1 (en) 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
TW201002332A (en) 2008-07-07 2010-01-16 Univ Nat Chunghsing Composition for preventing and controlling fatty liver disease
US8613959B2 (en) * 2009-02-10 2013-12-24 Fhg Corporation Dietary supplements containing extracts of Nelumbo and processes of using same
WO2010111518A1 (en) 2009-03-27 2010-09-30 Yale University Treatment and prevention of white matter injury with katp channel activators
ES2739976T3 (es) 2009-07-01 2020-02-05 Jds Therapeutics Llc Complejos de cromo como potenciadores de transportadores de glucosa cerebral
US9333228B2 (en) 2010-06-01 2016-05-10 Top Doctors Labs, Llc Nutritional supplement for recovery, repair, and maintenance
US20120028891A1 (en) 2010-07-29 2012-02-02 Hill's Pet Nutrition, Inc. Methods of promoting or maintaining an anabolic state in a female animal
WO2012119007A1 (en) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
JP5939819B2 (ja) 2012-01-31 2016-06-22 キヤノン株式会社 通信装置、通信装置の制御方法、通信システム、プログラム
JP6417339B2 (ja) 2013-03-08 2018-11-07 ヴィダシム・インコーポレーテッド 金属イオン−機能性繊維成分錯体組成物、その調製および使用
US20160220581A1 (en) 2015-01-30 2016-08-04 Jds Therapeutics, Llc Chromium compositions for the treatment or prevention of diabetic retinopathy
GB2587289B (en) 2015-06-23 2021-06-23 Jds Therapeutics Llc Chromium Histidinate Complexes
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身
CN107028178A (zh) * 2017-03-15 2017-08-11 汪盛华 一种雄才颗粒

Also Published As

Publication number Publication date
CA3014308A1 (en) 2017-08-17
US11865121B2 (en) 2024-01-09
WO2017139337A1 (en) 2017-08-17
GB201814745D0 (en) 2018-10-24
US20170239267A1 (en) 2017-08-24
EP3413900A1 (en) 2018-12-19
CN109069532A (zh) 2018-12-21
US20190216821A1 (en) 2019-07-18
AU2023200412A1 (en) 2023-02-23
US11857553B2 (en) 2024-01-02
AU2025201770A1 (en) 2025-04-03
GB2564295A (en) 2019-01-09
AU2017217466A1 (en) 2018-08-23
US20240148748A1 (en) 2024-05-09

Similar Documents

Publication Publication Date Title
BR112013000446A2 (pt) composição nutricional para a estimulação de síntese de proteína muscular
BR112015024757A2 (pt) métodos para aprimorar síntese de proteína muscular seguindo treinamento simultâneo
EA201491666A1 (ru) Способы повышения устойчивости скелетных мышц к утомлению
GB2564295A (en) Chromium containing compositions for improving health and fitness
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
PH12015501688B1 (en) Nutritional compositions containing magnesium threonate and uses thereof
MY182593A (en) Composition containing chitin and digestible proteins
EA201990579A1 (ru) Применение гидролизата коллагена для улучшения способности к выносливости и стимуляции расщепления жиров
EA201691436A1 (ru) Композиция, включающая окру для применения в уменьшении абсорбции пищевого жира
CY1112660T1 (el) Συμπληρωμα διατροφης που παρεχει ενεργεια σε σκελετικους μυες και που προστατευει την καρδιαγγειακη οδο
BR112018009396A8 (pt) composição bacteriana para uso em atenuar o declínio de desempenho após exercício
MX2018006355A (es) Producto alimenticio para reducir degradacion muscular y metodos del mismo.
MY209392A (en) Use of amino acid supplementation for improved muscle protein synthesis
PL417769A1 (pl) Kompozycja aminokwasowa na bazie białka do stosowania przed wysiłkiem fizycznym
PH12015501157A1 (en) Nutrition composition for promoting satiety
MY200278A (en) Methods of improving exercise capacity in fontan patients using udenafil compositions
BR112018074299A2 (pt) composições farmacêuticas compreendendo eteplirsen
MY179829A (en) Anti-regurgitation nutritional composition
Newman Thermogenesis, muscle hyperplasia, and the origin of birds
WO2013144267A3 (en) Improvement of musculoskeletal health by nutrition and exercise
WO2014016680A3 (ru) Многофункциональный эллиптический тренажер
EA201200870A1 (ru) Биологически активная добавка к пище
JP3183277U (ja) フィットネスシューズ
TH141000A (th) วิธีการเสริมสร้างการสังเคราะห์โปรตีนในกล้ามเนื้อ
Colosi Biography: Laura Colosi